Adamis Pharmaceuticals Announces Tempol Reduces Lung Inflammation in the COVID-19 Challenged Hamster Model

Press/Media: Expert Comment

PeriodMar 15 2021

Media coverage

18

Media coverage

Keywords

  • COVID-19